Your browser doesn't support javascript.
loading
Author Correction: Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry.
Zhang, Hua; Li, Yan; Wang, Hong-Bo; Zhang, Ao; Chen, Mei-Ling; Fang, Zhi-Xin; Dong, Xiao-Dong; Li, Shi-Bing; Du, Yong; Xiong, Dan; He, Jiang-Yi; Li, Man-Zhi; Liu, Yan-Min; Zhou, Ai-Jun; Zhong, Qian; Zeng, Yi-Xin; Kieff, Elliott; Zhang, Zhiqiang; Gewurz, Benjamin E; Zhao, Bo; Zeng, Mu-Sheng.
Afiliação
  • Zhang H; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology, South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Li Y; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Wang HB; Guangdong Provincial Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Zhang A; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology, South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Chen ML; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology, South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Fang ZX; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology, South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Dong XD; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology, South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Li SB; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology, South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Du Y; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology, South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Xiong D; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology, South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • He JY; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology, South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Li MZ; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology, South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Liu YM; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology, South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Zhou AJ; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology, South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Zhong Q; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology, South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Zeng YX; Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology, South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Kieff E; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Zhang Z; Immunobiology and Transplant Science Center, Houston Methodist Research Institute, Houston, TX, USA.
  • Gewurz BE; Department of Surgery, Weill Cornell Medical College of Cornell University, New York, NY, USA.
  • Zhao B; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Zeng MS; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. bzhao@bwh.harvard.edu.
Nat Microbiol ; 3(9): 1075, 2018 Sep.
Article em En | MEDLINE | ID: mdl-29679064

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Nat Microbiol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Nat Microbiol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China